How the $2,000 Drug Cap Saves Medicare Retirees This Year
Medicare’s new $2,000 out-of-pocket cap on Part D drugs is delivering real relief for retirees, with insulin costs ca...
Timing rebalancing for tax efficiency involves evaluating thresholds and market conditions. This intro offers actionable timing tips for index funds.
17,111 articlesMedicare’s new $2,000 out-of-pocket cap on Part D drugs is delivering real relief for retirees, with insulin costs ca...
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Powell pledges to stay on the Federal Reserve board until the DOJ probe concludes, as Trump presses to replace him. T...
The Federal Reserve held rates steady this week, but uncertainty remains. Three principal concerns are rattling inves...
The SEC is exploring a proposal that could let U.S. public companies report semiannually instead of quarterly, prompt...
The Justice Department filed a federal civil rights lawsuit against Harvard, alleging leadership failed to curb antis...
Lithium Americas has gained 32% in the last year as Thacker Pass advances, but rising share dilution and mounting cap...
The Supreme Court declined to review a high-profile press freedom dispute stemming from a 2017 Texas arrest. The move...
Kentucky lawmakers are advancing a consumer-protection bill tied to crypto kiosks that could force hardware wallet pr...
Viral getaway trends can spark inspiration, but they don’t always deliver. This guide breaks down the costs, realitie...
BlackRock's Larry Fink presents two stark paths for oil and markets tied to the Iran conflict, challenging households...
Bitcoin slipped from a brief rally as geopolitical headlines weighed on risk sentiment. Traders are watching on-chain...